ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 349447 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 349447; 2) Community: the network communities that were significantly associated with the response to NSC 349447; 3) Molecule: the relationships between components within communities and NSC 349447; 4) MDR: the compounds that were significantly associated with the NSC 349447.

NSC Compound Enrichment Correlation
NSC 724448 Null 0.000880521445136051 0.33858447
NSC 236580 .beta.-Alanine, N-[N-[N-[N-[1-(D-2-hydroxy-4-methyl-1-oxopentyl)-L-prolyl]-L-isoleucyl]-N-methyl-L-valyl]-N-methyl-L-alanyl]-, .rho.-lactone 0.000880521445136057 0.52442674
NSC 291926 Null 0.000880521445136057 0.23359706
NSC 632129 (E)-1-(2,5-Dihydroxyphenyl)ethene-2-isonitrile 0.000930692338491028 0.27715714
NSC 686553 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-phenyl- 0.000930692338491028 0.57635721
NSC 699092 Null 0.000930692338491028 0.45945222
NSC 174121 Methotrexate Derivative 0.000930692338491037 0.4456502
NSC 39215 Null 0.000931492155975089 0.057828882
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.000931492155975089 0.42044967
NSC 617394 Null 0.000931492155975089 0.31203261
Total:152  Current:7    [First] [Prev] [Next] [Last]